Orion Therapeutics
PrivateLast Round
Grant
Sep 15, 2025
Total Funding Raised
$2.03M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Orion Therapeutics operates in Healthcare & Life Sciences and is based in Knoxville, Tennessee. Its latest recorded funding round was a Grant round in September 2025.
Orion Therapeutics is a biotechnology company that develops RNA therapies and vaccines enabled by a novel delivery platform.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Platform-as-a-Service
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share, Government Contracts
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Orion Therapeutics Comparables
Compare Orion Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Hopewell Therapeutics | 86% | |
| Entos Pharmaceuticals | 81% | |
| Kamal Therapeutics, Inc. | 81% |
For institutional investors. Book with your work email.
Orion Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Sep 15, 2025 | ||||
| Pre Seed | Jul 9, 2024 | ||||
| Grant | Oct 24, 2023 | ||||
| Grant | Sep 12, 2023 | ||||
| Grant | May 4, 2023 | ||||
Accelerator | Sep 26, 2022 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Orion Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Tennessee Technology Development Corporation | Pre Seed, Grant |
| Nucleate | Grant |
| University of Tennessee Research Foundation | Pre Seed |
| National Science Foundation | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 25, 2026
Monthly visitors increased 30% to 1.9K.
- Jun 18, 2026
Monthly visitors grew 33% MoM.
For institutional investors. Book with your work email.
Orion Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Orion Therapeutics's valuation, stock price, and market status.
Is Orion Therapeutics a public or private company?
Orion Therapeutics is a private company.
What is the current stock price of Orion Therapeutics?
Orion Therapeutics is a private company, so its shares have no public market price. Caplight tracks Orion Therapeutics's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Orion Therapeutics worth (valuation)?
Valuation information for Orion Therapeutics is not publicly available.
Can I buy Orion Therapeutics stock?
Orion Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Orion Therapeutics's last funding round?
Orion Therapeutics's most recent funding round was Grant on September 15, 2025.
Who are the main investors in Orion Therapeutics?
Key investors in Orion Therapeutics include Tennessee Technology Development Corporation, National Science Foundation.
Will Orion Therapeutics IPO soon?
No public IPO plans have been announced for Orion Therapeutics.
How can I track Orion Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades in Orion Therapeutics's shares on secondary markets.